These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
612 related items for PubMed ID: 25698493
1. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW. Vaccine; 2015 Mar 24; 33(13):1602-7. PubMed ID: 25698493 [Abstract] [Full Text] [Related]
2. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E. Commun Dis Intell; 2000 Feb 17; 24(2):27-33. PubMed ID: 10758692 [Abstract] [Full Text] [Related]
3. Vaccine Allergy? Skin Testing and Challenge at a Tertiary Pediatric Hospital in Melbourne, Australia. Cheung A, Choo S, Perrett KP. J Allergy Clin Immunol Pract; 2019 Feb 17; 7(5):1541-1549. PubMed ID: 30682574 [Abstract] [Full Text] [Related]
8. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F. Travel Med Infect Dis; 2008 May 17; 6(3):130-6. PubMed ID: 18486068 [Abstract] [Full Text] [Related]
9. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system. Clothier HJ, Hosking L, Crawford NW, Russell M, Easton ML, Quinn JA, Buttery JP. Drug Saf; 2015 Jan 17; 38(1):79-86. PubMed ID: 25475539 [Abstract] [Full Text] [Related]
10. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Arch Dis Child; 2012 Jun 17; 97(6):487-90. PubMed ID: 22275307 [Abstract] [Full Text] [Related]
11. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM. Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526 [Abstract] [Full Text] [Related]
12. Surveillance of adverse events following immunisation: Australia, 2000-2002. Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, Purcell P, Isaacs D. Commun Dis Intell Q Rep; 2003 May 25; 27(3):307-23. PubMed ID: 14510057 [Abstract] [Full Text] [Related]
14. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Nakayama T, Aizawa C, Kuno-Sakai H. J Allergy Clin Immunol; 1999 Feb 25; 103(2 Pt 1):321-5. PubMed ID: 9949325 [Abstract] [Full Text] [Related]
15. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E. Vaccine; 2014 May 23; 32(25):3019-24. PubMed ID: 24699471 [Abstract] [Full Text] [Related]
16. Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Lawrence G, Boyd I, McIntyre P, Isaacs D. Commun Dis Intell Q Rep; 2006 May 23; 30(3):319-33. PubMed ID: 17120485 [Abstract] [Full Text] [Related]